Dragonfly system for leaky mitral valve in heart failure
Treatments studied
Part of Heart & circulation clinical trials.
This study tests a device called Dragonfly that may reduce mitral regurgitation, a leaky heart valve that can cause shortness of breath and fatigue. The device is placed through a small cut in the leg, avoiding open-heart surgery, and aims to improve symptoms and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have moderate-to-severe or severe functional mitral regurgitation (a leaky heart valve) due to heart muscle weakness, even if your heart muscle is healthy or not.
- The doctor can place the device through a vein in your leg and into the heart (called a transseptal procedure).
- You do not have other severe heart valve problems that require a separate surgery.
- You are not currently in another investigational drug or device study that would interfere.
- You are willing and able to give informed consent and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a catheter-based procedure (putting a small device through blood vessels) to repair a leaking mitral valve caused by heart muscle problems. It aims to reduce symptoms and improve heart function and safety in people who are still having heart failure symptoms despite standard treatment.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
This trial tests whether repairing a leaky heart valve (mitral valve) can help people with heart failure feel better and live longer, even when standard heart failure medicines are not working well. The repair is done through a small tube in a blood vessel, avoiding open-heart surgery.
This trial tests the safety and effectiveness of a heart procedure that repairs a leaking mitral valve through thin tubes, using the Dragonfly system. It’s for people who have significant mitral valve leak symptoms but are considered high risk for open-heart surgery.
This trial studies a new catheter-based valve replacement system for people with moderate to severe, or severe, mitral valve regurgitation (a leaky mitral valve). It aims to check whether the procedure is safe and can improve heart function compared with expected care.
This study tests a new device, called DragonFly M2, to fix a leaky heart valve (mitral valve) that is causing symptoms. The goal is to see if this clip can reduce the leak and improve your heart function.
Hear when a new Mitral Regurgitation Functional trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.